These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9190437)

  • 1. [Changes in insulin secretion in familial combined hyperlipemia].
    Ascaso JF; Sales J; Priego A; Merchante A; Carmena-Ramón R; Carmena R
    Med Clin (Barc); 1997 Apr; 108(14):530-3. PubMed ID: 9190437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia.
    Ascaso JF; Sales J; Merchante A; Real J; Lorente R; Martinez-Valls J; Carmena R
    Int J Obes Relat Metab Disord; 1997 May; 21(5):360-6. PubMed ID: 9152737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia.
    Ascaso JF; Real JT; Merchante A; Rodrigo A; Carmena R
    Metabolism; 2000 Dec; 49(12):1627-31. PubMed ID: 11145128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients.
    Ascaso JF; Merchante A; Lorente RI; Real JT; Martinez-Valls J; Carmena R
    Metabolism; 1998 May; 47(5):508-13. PubMed ID: 9591739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia].
    Ascaso JF; Sales J; Merchante A; Real JT; Lorente RI; Martínez-Valls J; Carmena R
    Rev Clin Esp; 1997 Nov; 197(11):735-9. PubMed ID: 9547191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives.
    Bredie SJ; Tack CJ; Smits P; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1465-71. PubMed ID: 9261281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in patients with familial combined hyperlipidemia and coronary artery disease.
    Ascaso JF; Lorente R; Merchante A; Real JT; Priego A; Carmena R
    Am J Cardiol; 1997 Dec; 80(11):1484-7. PubMed ID: 9399729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.
    ter Avest E; Abbink EJ; de Graaf J; Tack CJ; Stalenhoef AF
    Eur J Clin Invest; 2005 Sep; 35(9):558-64. PubMed ID: 16128862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine in subjects with familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; den Heijer M; Blom HJ; Stalenhoef AF
    Atherosclerosis; 2003 Jan; 166(1):111-7. PubMed ID: 12482557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
    Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
    J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI-1 levels are related to insulin resistance and carotid atherosclerosis in subjects with familial combined hyperlipidemia.
    Carratala A; Martinez-Hervas S; Rodriguez-Borja E; Benito E; Real JT; Saez GT; Carmena R; Ascaso JF
    J Investig Med; 2018 Jan; 66(1):17-21. PubMed ID: 28822973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
    Ariza CR; Frati AC; Gómez G; Almazán A
    Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
    Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances.
    Florez H; Ryder E; Campos G; Fernandez V; Morales LM; Valbuena H; Rincón E; Gómez ME; Raleigh X
    Invest Clin; 1999 Jun; 40(2):127-42. PubMed ID: 10390951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.
    van der Vleuten GM; Veerkamp MJ; van Tits LJ; Toenhake H; den Heijer M; Stalenhoef AF; de Graaf J
    Atherosclerosis; 2005 Dec; 183(2):355-60. PubMed ID: 16285998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of leptin, tumor necrosis factor-alpha, neuropeptide Y levels and their association with insulin resistance and insulin secretion function in normal glucose tolerant first-degree relatives of familial type 2 diabetic pedigrees].
    Ren Y; Li X; Tian H; Liang J; Zhang X; Yu H; Wang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1341-5. PubMed ID: 21374991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia.
    Martinez-Hervas S; Artero A; Martinez-Ibañez J; Tormos MC; Gonzalez-Navarro H; Priego A; Martinez-Valls JF; Saez GT; Real JT; Carmena R; Ascaso JF
    Eur J Clin Invest; 2016 Jul; 46(7):636-42. PubMed ID: 27208733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different postprandial lipid metabolism and insulin resistance between non-diabetic patients with and without coronary artery disease.
    Nakamura A; Monma Y; Kajitani S; Kozu K; Ikeda S; Noda K; Nakajima S; Endo H; Takahashi T; Nozaki E
    J Cardiol; 2015 Nov; 66(5):435-44. PubMed ID: 25840497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.
    de Graaf J; van der Vleuten GM; ter Avest E; Dallinga-Thie GM; Stalenhoef AF
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1269-75. PubMed ID: 17227806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.